Clinical evidence
Building the evidence base, transparently.
Pilot results, ongoing multi-center trials, and a publication pipeline targeting JAMA and Lancet Oncology.
Ongoing trials
3 sites · 500 patients · ClinicalTrials.gov NCT0XXXXXX
In progress
JAMA submission
Q4 2026 — primary endpoint readout
In progress
Lancet Oncology
Q1 2027 — secondary outcomes
In progress
Physician advisory board
Twelve KOLs across oncology, GI, urology, and diagnostics.
DAC
Dr. A. Chen
Chief of Oncology, Mayo Clinic
DMP
Dr. M. Patel
Prof. of Diagnostics, Johns Hopkins
DSW
Dr. S. Williams
Director of GI Research, Cleveland Clinic
DRO
Dr. R. Okafor
Urologic Oncology, MD Anderson
DLN
Dr. L. Nakamura
Pathology, Stanford
DER
Dr. E. Rossi
Translational Medicine, Karolinska